179 related articles for article (PubMed ID: 37263366)
1. Risks of neurological and psychiatric sequelae 2 years after hospitalisation or intensive care admission with COVID-19 compared to admissions for other causes.
Ley H; Skorniewska Z; Harrison PJ; Taquet M
Brain Behav Immun; 2023 Aug; 112():85-95. PubMed ID: 37263366
[TBL] [Abstract][Full Text] [Related]
2. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
[TBL] [Abstract][Full Text] [Related]
3. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records.
Taquet M; Geddes JR; Husain M; Luciano S; Harrison PJ
Lancet Psychiatry; 2021 May; 8(5):416-427. PubMed ID: 33836148
[TBL] [Abstract][Full Text] [Related]
4. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections.
Taquet M; Dercon Q; Harrison PJ
Brain Behav Immun; 2022 Jul; 103():154-162. PubMed ID: 35447302
[TBL] [Abstract][Full Text] [Related]
5. Neurological Sequelae of COVID-19.
Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
[TBL] [Abstract][Full Text] [Related]
6. Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study.
Ray STJ; Abdel-Mannan O; Sa M; Fuller C; Wood GK; Pysden K; Yoong M; McCullagh H; Scott D; McMahon M; Thomas N; Taylor M; Illingworth M; McCrea N; Davies V; Whitehouse W; Zuberi S; Guthrie K; Wassmer E; Shah N; Baker MR; Tiwary S; Tan HJ; Varma U; Ram D; Avula S; Enright N; Hassell J; Ross Russell AL; Kumar R; Mulholland RE; Pett S; Galea I; Thomas RH; Lim M; Hacohen Y; Solomon T; Griffiths MJ; Michael BD; Kneen R;
Lancet Child Adolesc Health; 2021 Sep; 5(9):631-641. PubMed ID: 34273304
[TBL] [Abstract][Full Text] [Related]
7. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis.
Premraj L; Kannapadi NV; Briggs J; Seal SM; Battaglini D; Fanning J; Suen J; Robba C; Fraser J; Cho SM
J Neurol Sci; 2022 Mar; 434():120162. PubMed ID: 35121209
[TBL] [Abstract][Full Text] [Related]
8. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.
Rogers JP; Chesney E; Oliver D; Pollak TA; McGuire P; Fusar-Poli P; Zandi MS; Lewis G; David AS
Lancet Psychiatry; 2020 Jul; 7(7):611-627. PubMed ID: 32437679
[TBL] [Abstract][Full Text] [Related]
9. Neurological disorders associated with COVID-19 in Sri Lanka.
Chang T; Wijeyekoon R; Keshavaraj A; Ranawaka U; Senanayake S; Ratnayake P; Senanayake B; Caldera MC; Pathirana G; Sirisena D; Wanigasinghe J; Gunatilake S;
BMC Neurol; 2023 Oct; 23(1):351. PubMed ID: 37794324
[TBL] [Abstract][Full Text] [Related]
10. Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network.
Raiker R; Pakhchanian H; DeYoung C; Gupta L; Kardeş S; Ahmed S; Kavadichanda C
J Autoimmun; 2021 Dec; 125():102730. PubMed ID: 34649723
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of Neurological Manifestations in Covid-19: A Review.
Garg RK
Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
[TBL] [Abstract][Full Text] [Related]
12. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
[TBL] [Abstract][Full Text] [Related]
13. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
[TBL] [Abstract][Full Text] [Related]
14. Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis.
Vai B; Mazza MG; Delli Colli C; Foiselle M; Allen B; Benedetti F; Borsini A; Casanova Dias M; Tamouza R; Leboyer M; Benros ME; Branchi I; Fusar-Poli P; De Picker LJ
Lancet Psychiatry; 2021 Sep; 8(9):797-812. PubMed ID: 34274033
[TBL] [Abstract][Full Text] [Related]
15. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study.
Varatharaj A; Thomas N; Ellul MA; Davies NWS; Pollak TA; Tenorio EL; Sultan M; Easton A; Breen G; Zandi M; Coles JP; Manji H; Al-Shahi Salman R; Menon DK; Nicholson TR; Benjamin LA; Carson A; Smith C; Turner MR; Solomon T; Kneen R; Pett SL; Galea I; Thomas RH; Michael BD;
Lancet Psychiatry; 2020 Oct; 7(10):875-882. PubMed ID: 32593341
[TBL] [Abstract][Full Text] [Related]
16. Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up.
Nersesjan V; Amiri M; Lebech AM; Roed C; Mens H; Russell L; Fonsmark L; Berntsen M; Sigurdsson ST; Carlsen J; Langkilde AR; Martens P; Lund EL; Hansen K; Jespersen B; Folke MN; Meden P; Hejl AM; Wamberg C; Benros ME; Kondziella D
J Neurol; 2021 Sep; 268(9):3086-3104. PubMed ID: 33438076
[TBL] [Abstract][Full Text] [Related]
17. Neurological Complications Associated With SARS-CoV-2 Infection: A Single-Centre Experience.
Martins M; Pereira A; Teixeira A; Lima D; Lopes N; Amaral-Silva M; Seixo I; Miguéns AC
Cureus; 2022 Dec; 14(12):e32655. PubMed ID: 36654564
[TBL] [Abstract][Full Text] [Related]
18. Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes: A Retrospective Cohort Study.
Ramakrishnan D; Sureshanand S; Pittman B; Radhakrishnan R
J Clin Psychiatry; 2022 Aug; 83(5):. PubMed ID: 36044600
[No Abstract] [Full Text] [Related]
19. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]